27 genes were significantly up or downregulated more than 1.5-fold (22 up/5 down, Wald’s test against a null hypothesis of 0.585 LFC), among which were FABP4 and CD36, which we previously identified as differentially expressed at SARIFAs in gastric cancer [8]. Here, FABP4 is linked to gastric cancer.